MasterClass: Next Generation Presbyopia-Correcting IOLs -

Name: MasterClass: Next Generation Presbyopia-Correcting IOLs
Uploaded: 2022-07-01T04:00:00+00:00
Duration: 11 min 46 s
Description: In this MasterClass, Dr. Marc Bloomenstein discusses the newest presbyopia-correcting IOLS. By the end of this class, you will understand the optical desig

Overview
In this MasterClass, Dr. Marc Bloomenstein discusses the newest presbyopia-correcting IOLS. By the end of this class, you will understand the optical designs and indications for enhanced monofocals, next-generation extended range of vision IOLS, and hybrid multifocals. You will also be able to identify the best candidates for these presbyopia-correcting IOLs.
This independent educational activity is supported by unrestricted educational grants from Johnson & Johnson Vision and Visus Therapeutics.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Identify how the latest presbyopia-correcting IOL technologies can create new groups of satisfied presbyopia-correcting IOL patients, including those with enhanced monofocals, extended range of vision IOLs, and comorbid conditions
Accreditation
Sponsored by
Evolve Medical Education LLC (Evolve) is a COPE-accredited administrator.
This activity, COPE Activity Number 124265, is accredited by COPE for continuing education for optometrists for 0.25 hours.
Course #: 78858-GO
Activity #: 124265
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
Participation Method
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Faculty and Disclosures
Marc R. Bloomenstein, OD, FAAO
Schwartz Laser Eye Center
Director of Optometric Services
Scottsdale, AZ

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Marc R. Bloomenstein, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Aerie Pharmaceuticals, Allergan, Azura, Bausch + Lomb, Johnson & Johnson Vision, Kala Pharmaceuticals, OcuSoft, Sight Sciences, Sun Pharmaceutical Industries, and Tarsus. Grant/Research Support: Sight Sciences. Speaker’s Bureau: Allergan, Bausch + Lomb, Johnson & Johnson Vision, Kala Pharmaceuticals, OysterPoint, RVL, Sight Sciences, and Sun Pharmaceutical Industries.
The Evolve and The Fundingsland Group staff, planners, and reviewers have no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group, Johnson & Johnson Vision, or Visus Therapeutics.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date: 07/01/2022
Expiration Date: 07/31/2023

Marc R. Bloomenstein, OD, FAAO

Guest

MasterClass: Next Generation Presbyopia-Correcting IOLs

Recommended

Title